![Joe Bolen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joe Bolen
Chief Executive Officer at
Orna Therapeutics, Inc.
Profile
Joseph B. Bolen is currently Chief Executive Officer at Orna Therapeutics, Inc. starting in 2025 and serves as an Independent Director at Aelin Therapeutics NV.
Formerly, Dr. Bolen was Chief Scientific Officer at PureTech Health Plc from 2016 to 2023, Partner at MPM BioImpact LLC in 2026, President & Chief Scientific Officer at Moderna, Inc. and ModernaTX, Inc., Vice President & Head-Oncologic Diseases at Hoechst Marion Roussel, Inc., Advisor at Robert Wood Johnson Medical School, Scientist at National Institutes of Health, Professor & Member-Graduate Faculty at Princeton University, Member-Scientific Advisory Board at Rutgers State University of New Jersey, Chief Scientific Officer & Head-Oncology Research at Millennium Pharmaceuticals, Inc., Founding Director at DNAX Research, Inc., and Director-Cellular Signaling Department at Bristol-Myers Squibb Pharma Research Labs LLC in 2012.
Education includes undergraduate studies at the University of Nebraska and a doctorate from Kansas State University.
Joe Bolen active positions
| Companies | Position | Start |
|---|---|---|
Aelin Therapeutics NV
 Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops drugs for antibiotics and first-in-class therapeutics | Director/Board Member | - |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Chief Executive Officer | 30/03/2025 |
Former positions of Joe Bolen
| Companies | Position | End |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 31/05/2026 |
| PURETECH HEALTH PLC | Chief Tech/Sci/R&D Officer | 31/01/2023 |
| MODERNA, INC. | President | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Chief Tech/Sci/R&D Officer | - |
DNAX Research, Inc. | Corporate Officer/Principal | - |
Training of Joe Bolen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Bristol-Myers Squibb Pharma Research Labs LLC
 Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Researches & develops drugs and related pharmaceutical products | Commercial Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kansas State University
 Kansas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
DNAX Research, Inc. | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Aelin Therapeutics NV
Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops drugs for antibiotics and first-in-class therapeutics | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
- Stock Market
- Insiders
- Joe Bolen
